Reagent kit for determining the activity of creatine kinase MB fraction in serum and plasma by kinetic UV method (Creatine kinase MB IFCC) according to TU 9398-629-23548172-2016 1) - reagent 1 - 4 vials (20 ml each); - reagent 2 - 4 vials (5 ml each); 2) - reagent 1 - 4 vials (48 ml each); - reagent 2 - 4 vials (14 ml each); for the MIURA automatic analyzer; 3) - reagent 1 - 4 vials (42 ml each); - reagent 2 - 2 vials (22 ml each); for the automatic analyzer ILab Taurus; 4) - reagent 1 - 2 vials (40 ml each); - Reagent 2 - 1 vial (20 ml); for automatic analyzer BA400; 5) - reagent 1 - 2 vials (36 ml each); - reagent 2 - 2 vials (10 ml each); for the Aspect Automatic Analyzer. - Roszdravnadzor Registration РЗН 2017/6454

Access comprehensive regulatory information for Reagent kit for determining the activity of creatine kinase MB fraction in serum and plasma by kinetic UV method (Creatine kinase MB IFCC) according to TU 9398-629-23548172-2016 1) - reagent 1 - 4 vials (20 ml each); - reagent 2 - 4 vials (5 ml each); 2) - reagent 1 - 4 vials (48 ml each); - reagent 2 - 4 vials (14 ml each); for the MIURA automatic analyzer; 3) - reagent 1 - 4 vials (42 ml each); - reagent 2 - 2 vials (22 ml each); for the automatic analyzer ILab Taurus; 4) - reagent 1 - 2 vials (40 ml each); - Reagent 2 - 1 vial (20 ml); for automatic analyzer BA400; 5) - reagent 1 - 2 vials (36 ml each); - reagent 2 - 2 vials (10 ml each); for the Aspect Automatic Analyzer. in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number РЗН 2017/6454 and manufactured by JSC "Vector-Best". The device was registered on August 16, 2024.

This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.